INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 427m ago
HOUSE PTR27m ago
SEC 13F27m ago
ROBINHOOD CHAIN26m ago
Public company

FHTXFoghorn Therapeutics Inc.

CIK 0001822462

EDGAR filingsOpen in network
Disclosed transactions9
Buys / sells0 / 0
Max Insider Score20
Connections7with evidence

FHTX · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
12
GN
Gallagher NeilDirector
FHTXFoghorn Therapeutics Inc.
Grant or award
A$114K
28.0K sh
Jun 24, 2026Jun 25, 2026
traded Jun 24, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Gallagher NeilDirector · Jun 25, 2026
  • ← Insider ofevidence
    Duty StuartDirector · Jun 25, 2026
  • ← Insider ofevidence
    Gottschalk AdrianDirector, Chief Executive Officer · Feb 6, 2026
12
DS
Duty StuartDirector
FHTXFoghorn Therapeutics Inc.
Grant or award
A
$114K
28.0K sh
Jun 24, 2026
Jun 25, 2026
traded Jun 24, 2026
+1d
SEC FORM 4

Evidence

20
GA
Gottschalk AdrianDirector, Chief Executive Officer
FHTXFoghorn Therapeutics Inc.
Gift
G—
59.2K sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC FORM 4

Evidence

20
GA
Gottschalk AdrianDirector, Chief Executive Officer
FHTXFoghorn Therapeutics Inc.
Gift
G—
47.5K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC FORM 4

Evidence

12
GA
Gottschalk AdrianDirector, Chief Executive Officer
FHTXFoghorn Therapeutics Inc.
Gift
G—
47.5K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC FORM 4

Evidence

20
GA
Gottschalk AdrianDirector, Chief Executive Officer
FHTXFoghorn Therapeutics Inc.
Gift
G—
59.2K sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC FORM 4

Evidence

18
GA
Gottschalk AdrianDirector, Chief Executive Officer
FHTXFoghorn Therapeutics Inc.
Grant or award
A$5.62M
1.07M sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC FORM 4

Evidence

18
CC
Costa CarlosChief People Officer
FHTXFoghorn Therapeutics Inc.
Grant or award
A$1.31M
230.0K sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC FORM 4

Evidence

15
RA
Rivkin AnnaChief Business Officer
FHTXFoghorn Therapeutics Inc.
Grant or award
A$942K
165.0K sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC FORM 4

Evidence

← Insider ofevidence
Rivkin Anna
Chief Business Officer · Feb 2, 2026
  • ← Insider ofevidence
    Costa CarlosChief People Officer · Feb 2, 2026
  • ← Insider ofevidence
    Humer KristianChief Financial Officer · Nov 17, 2025